Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3149-3156

  Tanamoto, Ken Ichi ^a   Azumi, Satoko ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GLUCOSAMINE; LIPID A; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN U937; CHEMICAL STRUCTURE; ESCHERICHIA COLI; GAS LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID COMPOSITION; LIPOGENESIS; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; PRIORITY JOURNAL; RABBIT; SALMONELLA;

EID: 0034653876     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3149     Document Type: Article

References (39)

1. Müller-Loennies, S., L. Zähringer, U. Seydel, S. Kusumoto, A. J. Ulmer, and E. Th. Rietschel. 1998. What we know and don't know about the chemical and physical structure of lipopolysaccharide in relation to biological activity. In Endotoxin and Sepsis. J. Levin, M. Pollack, T. Yokochi, and M. Nakano, eds. Wiley-Liss, New York, p. 37.
2. Omar, A. S., H. T. Flammann, D. Borowiak, and J. Weckesser. 1983. Lipopolysaccharide of two strains of the phototrophic bacterium Rhodopseudomonas capsulata. Arch. Microbiol. 134:212.
3. Qureshi, N., K. Takayama, and R. Kurtz. 1991. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect. Immun. 59:441.
4. Strittmatter, W., W. Weckesser, P. V. Salimath, and C. Galanos. 1983. Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J. Bacteriol. 155:153.
5. Tanamoto, K., C. Galanos, O. Lüeritz, S. Kusumoto, and T. Shiba. 1984. Mitogenic activities of synthetic lipid A analogues and suppression of mitogenicity of lipid A. Infect, Immun. 44:427.
6. Christ, W. J., O. Asano, A. L. C. Robidoux, M. Perez, Y. Wang, G. R. Dubuc, W. E. Gavin, L. D. Hawkins, P. D. McGuinness, M. A. Mularkey, et al. 1995. E5531, a pure endoloxin antagonist of high potency. Science 268:80.
7. Tanamoto, K. 1994. Predominant role of the substituents on the hydroxyl groups of 3-hydroxy fatty acids of non-reducing glucosamine in lipid A for the endotoxic and antagonistic activity. FEBS Lett. 351:325.
8. Tanamoto, K. 1995. Chemically detoxified lipid A precursor derivatives antagonize the TNF-α-inducing action of LPS in both murine macrophages and a human macrophagc cell line. J. Immunol. 155:5391.
9. Loppnow, H., H. Brade, I. Durrbaum, and C. A. Dinarello. 1989. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J. Immunol. 142:3229.
10. Kovach, N., E. Yee, R. S. Munford, C. R. H. Raetz, and J. M. Harlan. 1990. Lipid IVa inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human blood ex vivo. J. Exp. Med. 172:77.
11. Golenbock, D. T., R. Y. Hampton, N. Qureshi, K. Takayama, and C. R. H. Raetz. 1991. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266:19490.
12. Imoto, M., H. Yoshimura, M. Yamamoto, T. Shimamoto, S. Kusumoto, and T. Shiba. 1984. Chemical synthesis of phosphorylated tetraacyl disaccharide corresponding to a biosynthetic precursor of lipid A. Tetrahedron Lett. 25:2667.
13. Imoto, M., H. Yoshimura, N. Sakaguchi, S. Kusumoto, and T. Shiba. 1984. Total synthesis of Escherichia coli lipid A. Tetrahedron Lett. 26:1545.
14. Kusumoto, S., H. Yoshimura, M. Imoto, T. Shimamoto, and T. Shiba. 1985. Chemical synthesis of 1-dephospho derivative Escherichia lipid A. Tetrahedron Lett. 26:909.
15. Galanos, C., O. Lüeritz, M. A. Freudenberg, E. Th. Rietschel, O. Westphal, H. Brade, L. Brade, U. Shade, M. Imoto, H. Yoshimura, et al. 1985. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148:1.
16. Homma, J. Y., M. Matsuura, S. Kanegasaki, Y. Kawakuho, Y. Kojima, N. Shibukawa, Y. Kumazawa, A. Yamamoto, K. Tanamoto, T. Yasuda, et al. 1985. Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J. Biochem. 98:395.
17. Kotani, S., H. Takada, M. Tsujimoto, T. Ogawa, I. Takahashi, T. Ikeda, K. Otsuka, H. Shimauchi, N. Kasai, J. Mashimo, et al. 1985. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from Escherichia coli Re-mutant. Infect. Immun. 49:225.
18. Galanos, C., O. Lüderiz, M. Freudenberg, L. Brade, U. Schade, E. Th. Rietschel, S. Kusumoto, and T. Shiba, 1986. Biological activity of synthetic heptaacyl lipid A representing a component of Salmonella minnesota R595 lipid A. Eur. J. Biochem. 160:55.
19. Kanegasaki, S., K. Tanamoto, T. Yasuda, J. Y. Homma, M. Matsuura, M. Nakatsuka, Y. Kumazawa, A. Yamamoto, T. Shiba, S. Kusumoto, et al. 1986. Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid As with different fatty acid compositions. J. Biochem. 99:1203.
20. Kotani, S., H. Takada, I. Takahashi, M. Tsujimoto, T. Ogawa, T. Ikeda, K. Harada, H. Okamura, T. Tamura, and S. Tanaka. 1986. Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of β(1-6)glucosamine disaccharide 1-4′-bisphosphate. Infect. Immun. 52:872.
21. Galanos, C., O. Lüderitz, and O. Westphal. 1969. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9:245.
22. Galanos, C., O. Lüderitz, and O. Westphal. 1971. Preparations and properties of antisera against the lipid A component of bacterial lipopolysaccharides. Eur. J. Biochem. 24:116.
23. Tanamoto, K. 1994. Induction of prostaglandin release from macrophages by bacterial endotoxin. In Methods in Enzymology, Vol. 236. V. L. Clark, and P. M. Bavoil, eds. Academic Press, San Diego, CA, p. 31.
24. Kitchens, R. L., T. R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophages cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485.
25. Roberts, F. A., G. J. Richardson, and S. M. Michalek. 1997. Effects of Prophyromonas gingivalis and Escherichia coli lipopolysacharides on mononuclear phagocytes. Infect. Immun. 65:3248.
26. Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells J. Biol. Chem. 268:11803.
27. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365:182.
28. Mellits, K. H., R. T. Hay, and S. Goodboum. 1993. Proteolytic degradation of MAD3 (IκB-α) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB Nucleic Acids Res. 21:5059.
29. Muroi, M., Y. Muroi, N. Ito, N. R. Rice, and T. Suzuki. 1995. Effects of proleasc inhibitors on LPS-mediated activation of a mouse macrophage cell line (J774). J. Endotoxin Res. 2:337.
30. Rietschel, E. T., H. W. Wollenweber, R. Russa, H. Brade, and U. Zahringer. 1984. Concepts of the chemical structure of lipid A. Rev. Infect. Dis. 6:432.
31. Rietschel, E. T., H.-W. Wollenweber, H. Brade, U. Zährinber, B. Lindner, U. Seydel, H. Bradaczek, G. Barnickel, H. Labischinski, and P. Giesbrecht. 1984. Structure and conformation of the lipid A component of lipopolysaccharides. In Handbook of Endotoxin, Vol. 1. R. A. Proctor, ed. Elsevier Science Publishers. Amsterdam, p. 187.
32. Grabarek, J., G. R. Her, V. N. Reinhold, and J. Hawiger. 1990. Endotoxic lipid A interaction with human platelets: structure-function analysis of lipid A homologs obtained from Salmonella minnesota Re 595 lipopolysaccharide. J. Biol. Chem. 265:8117.
33. Galanos, C., V. Lehmann, O. Lüderitz, E. T. Rietschel, O. Westphal, H. Brade, L. Brade, M. A. Freudenberg, T. Hansen-Hagge, T. Lüderitz, et al. 1984. Endotoxic properties of chemically synthesized lipid A part structures: comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic precursor and free lipid A. Eur. J. Biochem. 140:221.
34. Yang, R.B., M.R. Mark, A. Gray, A. Huang, M.H. Xie, M. Zang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.
35. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4. J. Exp. Med. 189:1777.
36. Galanos, C., O. Lüderiz, E. T. Reitschel, and O. Westphal. 1977/ Newer aspects of the chemistry and biology of bacterial lipopolysaccharides with special reference to their lipid A component. In Biochemistry of lipids II, T. W. Goodwin, ed. University Park Press, Baltimore, p. 371.
37. Munford, R. S., and C. L. Hall. 1989. Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial liopoplysaccharides. J. Biol. Chem. 264:15613.
38. Erwin, A. L., and R. S. Munford. 1990. Deacylation of structureally diverse liopoplysaccharides by human acyloxyacyl hydrolase. J. Biol. Chem. 265:16444.
39. Tanamoto, K. 1995. Dissociation of endotoxic activities in a chemically synthesized lipid A precuresor after acetylation. Infect. Immun. 63:690.